Project Grant CE152072
- This $2,975,000 Project Grant award from the U.S. Department of Health and Human Services' Healthcare Systems Bureau (CFDA 93.493 - Congressional Directives) will enable Lawrence General Hospital to replace outdated hospital beds across its maternity, telemetry, intensive care, and medical-surgical units. The grant will fund the standardization of state-of-the-art hospital bed technology, enhancing patient comfort, improving equipment reliability, and reducing maintenance costs and staff strain....
- This federal Project Grant award of $577,000 from the U.S. Department of Health and Human Services (HHS) Healthcare Systems Bureau was provided to the Elliot Hospital of the City of Manchester in New Hampshire under the Congressional Directives (CFDA 93.493) program. The funding will be used to upgrade the hospital's mammography imaging capabilities by replacing aging equipment with high-resolution 3D mammography technology. This upgrade will enable the hospital to take one tomographic image and...
- Federal Project Grant Award Summary Massachusetts General Hospital (MGH) received a $578,070 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) awarded August 1, 2025, with completion targeted for July 1, 2026. The award funds the acquisition and installation of the OmniTom Elite Photon Counting Mobile Computed Tomography (CT) Scanner from NeuroLogica. This compact, self-shielded research instrument will be...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $759,658 Project Grant to Massachusetts General Hospital (MGH) on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) for development and validation of mechanomicroscopy technology. This four-year initiative, concluding June 30, 2029, focuses on creating an endoscopic imaging platform capable of diagnosing pulmonary hypertension (PH) due to lung disease (Group 3 PH)...
- The U.S. Department of Health and Human Services, through its Congressional Directives program (CFDA 93.493), awarded a $1,500,000 Project Grant to Deborah Heart & Lung Center to acquire a second computed tomography (CT) scan machine. This additional CT scanner will benefit the medically underserved populations in Burlington, Monmouth, and Ocean Counties, New Jersey, by improving diagnostic capabilities, reducing wait times, and enhancing continuity of care, particularly for emergency...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $1,835,840 Project Grant award dated August 1, 2025, under the Research Infrastructure Programs (CFDA 93.351) administered by the National Institutes of Health Office of the Director. The award funds the acquisition and installation of a clinical-grade NVision Polaris C13 Polarizer, an FDA-approved instrument that enables hyperpolarized carbon-13 (C13) magnetic resonance imaging (MRI). This specialized equipment...
- Federal Project Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $194,080 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective February 15, 2026, with completion targeted for August 17, 2027. The award supports mixed-methods health services research aimed at improving care for patients with Acute Type A Aortic Dissection (ATAAD), a life-threatening...
- Federal Project Grant Award Summary Aust Development, LLC received a $313,302 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 15, 2025, with completion targeted by August 31, 2026. The company is developing a precision lead delivery platform designed to improve cardiac conduction system (CCS) pacing, specifically targeting left bundle branch area pacing (LBBAP) procedures. The...
- Federal Project Grant Award Summary Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $793,868 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of May 31, 2030. The award supports the development and validation of machine learning (ML) methods to improve the automated diagnosis of aortic stenosis (AS) from cardiac...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $656,750 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a three-year project period concluding July 31, 2028. The award funds research to develop and optimize Electrical Impedance Tomography (EIT) as a bedside imaging tool for assessing lung perfusion in acute...
COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - CONSTRUCTION - LGH SEEKS TO REPLACE ITS EXISTING OLDER IMAGING EQUIPMENT IN ITS CARDIAC CATHETERIZATION LABORATORY WITH NEW STATE-OF-THE-ART EQUIPMENT TO DIAGNOSE AND TREAT HEART CONDITIONS SUCH AS CLOGGED ARTERIES OR IRREGULAR HEARTBEATS. DURING CARDIAC CATHETERIZATION CARDIOLOGISTS TEST THE HEART AND DELIVER TREATMENTS SUCH AS CORONARY ANGIOPLASTY AND CORONARY STENTING. WITH MORE THAN 70,000 EMERGENCY VISITS EACH YEAR, CARDIAC CARE IS A CRITICAL COMPONENT OF LAWRENCE GENERAL'S CARE DELIVERY. PATIENTS WHO PRESENT TO THE LGH EMERGENCY CENTER WITH A CARDIAC ISSUE OFTEN REQUIRE A CARDIAC CATHETERIZATION, A PROCEDURE IN WHICH A THIN, FLEXIBLE TUBE (CATHETER) IS GUIDED THROUGH A BLOOD VESSEL TO THE HEART TO DIAGNOSE OR TREAT CERTAIN HEART CONDITIONS. IT IS IMPERATIVE THAT LGH REPLACE THEIR CURRENT EQUIPMENT WITH NEW EQUIPMENT WHICH WILL BE IN SERVICE FOR THE NEXT DECADE, AND ENSURE THAT THE COMMUNITY HAS ACCESS TO DIAGNOSTIC AND EMERGENCY CARDIAC CARE FOR UNDERSERVED POPULATIONS. THE CARDIAC CATH LAB AT LGH WAS ESTABLISHED IN 1992 AND HAS BEEN RECOGNIZED AS A LEADER IN CARDIOVASCULAR CARE. THE LAB WAS RECOGNIZED AS A TOP FACILITY FOR CARDIOVASCULAR CARE IN THE 2022 EDITION OF U.S. NEWS & WORLD REPORT'S "BEST HOSPITALS" GUIDE. OVER THE COURSE OF THE LAB'S HISTORY, LGH HAS COMMITTED TO HIGH LEVELS OF PERFORMANCE EVALUATION AND REPORTING, ALONG WITH ITERATIVE PROCESSES OF IMPROVEMENT. AS A RESULT, LGH'S CARDIAC CATH LAB IS AMONG THE MOST THOROUGHLY ACCREDITED AND RECOGNIZED HOSPITAL IN MA - - EVEN MORE THAN SIMILAR LABS IN BOSTON. THROUGH THE AMERICAN COLLEGE OF CARDIOLOGY, LGH'S LAB HOLDS CHEST PAIN, CATH LAB, AND HEART FAILURE ACCREDITATIONS (THE ONLY HOSPITAL IN MA WITH THIS ACCREDITATION). LGH IS ALSO ONE OF ONLY A FEW HOSPITALS RECOGNIZED WITH THE HEARTCARE CENTER NATIONAL DISTINCTION OF EXCELLENCE. IT IS IMPERATIVE THAT PATIENTS WHO RECEIVE CARE AT LGH'S CARDIAC CATH LAB HAVE ACCESS TO THE BEST DIAGNOSTIC IMAGING TECHNOLOGY AVAILAB LE. THE PROPOSED NEW TECHNOLOGY WILL INCREASE THE NUMBER AND TYPE OF PROCEDURES LGH CAN CARRY OUT, REDUCING PATIENT TIME ON THE TABLE, AND REDUCING RADIATION EXPOSURE TO PATIENTS AND CLINICIANS ALIKE. BY PROVIDING THE HIGHEST QUALITY IMAGING AND CARE, THIS EQUIPMENT WILL IMPROVE ACCURACY, SAFETY, AND PATIENT EXPERIENCE AND HEALTH OUTCOMES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/5/26 | ||
| Not listed | $0 | 2/9/26 | ||
| Not listed | $0 | 2/9/26 | ||
| Not listed | $0 | 7/7/25 | ||
| Not listed | $0 | 7/7/25 |